GO:0120544 polypeptide conformation or assembly isomerase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0120544 describes a molecular function: catalysis of a reaction that alters the conformation or assembly of a polypeptide, as defined by QuickGO.
• This activity is distinct from folding chaperones because it actively isomerizes polypeptide conformation or assembly states rather than simply shielding aggregation-prone surfaces.
• Polypeptide conformational transitions are central to protein misfolding and aggregation diseases, including neurodegeneration.
• Experimental analysis of polypeptide conformation relies on NMR, circular dichroism, and computational conformational analysis of model polypeptides.
• Multiprotein assemblies such as Mediator and the TELO2-TTI1-TTI2 complex illustrate how ordered polypeptide assembly is studied structurally.
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of genes linked to polypeptide conformation or assembly isomerase activity.
Description
GO:0120544, polypeptide conformation or assembly isomerase activity, is a molecular function term in the Gene Ontology that describes catalysis of a reaction altering the conformation or assembly of a polypeptide. In practical terms, this activity covers enzymes or catalytic processes that change how a polypeptide chain is folded or how polypeptide subunits are assembled into higher-order complexes, rather than merely binding or stabilizing them. Because protein function depends critically on three-dimensional conformation and on correct assembly into complexes, this activity sits at the interface of protein folding, quality control, and macromolecular assembly. Researchers encounter this term when annotating enzymes that isomerize polypeptide states, when studying conformational diseases, and when dissecting assembly pathways of large multiprotein machines. The term is also relevant to experimental biophysics, where model polypeptides are used to understand how sequence and environment dictate conformation. Understanding GO:0120544 therefore helps connect molecular-level catalytic events to cellular assembly outcomes and to disease mechanisms rooted in misfolding or misassembly.
polypeptide conformation or assembly isomerase activity At A Glance
| GO ID | GO:0120544 |
|---|---|
| GO term | polypeptide conformation or assembly isomerase activity |
| Ontology | molecular_function |
| Synonym | None listed |
| Definition | Catalysis of a reaction that alters the conformation or assembly of a polypeptide |
| Major function | Catalytic alteration of polypeptide conformation or assembly state |
| Biological context | Protein folding, conformational transitions, and multiprotein assembly |
| Disease relevance | Protein misfolding and aggregation disorders, including neurodegeneration |
| Research methods | NMR, circular dichroism, structural biology, and CRISPR-based perturbation |
What Is GO:0120544?
According to the QuickGO definition, GO:0120544 (polypeptide conformation or assembly isomerase activity) is the catalysis of a reaction that alters the conformation or assembly of a polypeptide. This is a molecular_function term. It does not describe a specific protein or complex; instead, it classifies catalytic activities that change polypeptide conformation or the assembly state of polypeptide-containing structures. The term has no listed synonyms in the provided QuickGO data. It is broader than a single enzyme class and can be applied to any gene product or complex that catalyzes such conformational or assembly isomerization reactions.
Why Is polypeptide conformation or assembly isomerase activity Important in Cell Biology?
GO:0120544 matters because the conformation and assembly state of a polypeptide determine its biological activity, stability, and interactions. When conformational or assembly isomerization goes wrong, proteins can misfold and aggregate, a process linked to neurodegeneration and other proteinopathies. Conversely, correct assembly of large multiprotein complexes, such as Mediator or the TELO2-TTI1-TTI2 complex, depends on ordered polypeptide assembly steps that can be studied structurally. By defining a catalytic activity that alters polypeptide conformation or assembly, GO:0120544 provides a precise annotation target for enzymes and complexes that remodel polypeptide states, enabling researchers to connect molecular catalysis to cellular assembly and disease.
• Provides a formal GO annotation for catalytic activities that change polypeptide conformation or assembly, improving functional genomics.
• Links directly to protein misfolding and aggregation, a hallmark of neurodegenerative disease.
• Supports mechanistic studies of large multiprotein assemblies such as Mediator and TELO2-TTI1-TTI2.
• Enables interpretation of conformational data from NMR and circular dichroism experiments on model polypeptides.
• Helps distinguish isomerase-like conformational catalysis from passive chaperone binding.
• Guides CRISPR-based causal testing of candidate genes involved in polypeptide assembly.
• Informs drug discovery targeting conformational transitions and assembly interfaces.
• Connects biophysical polypeptide conformation studies to cellular and disease phenotypes.
• Supports annotation of enzyme families whose substrates are polypeptide chains rather than small molecules.
• Facilitates cross-species comparison of assembly and folding pathways.
Molecular Mechanism of polypeptide conformation or assembly isomerase activity
Substrate recognition and conformational transition
In simple terms: The enzyme first binds a polypeptide and then changes its shape or how it is put together.
For GO:0120544, the substrate is a polypeptide whose conformation or assembly state is altered by catalysis. Conformational transitions in polypeptides are governed by intrinsic sequence properties and environmental conditions, as shown by NMR and computational studies of model polypeptides. The catalytic event lowers the barrier for a conformational or assembly change, distinguishing this activity from simple binding. Because misfolding and aggregation arise from aberrant conformational transitions, understanding substrate recognition is central to this GO term.
Catalytic mechanism and energy landscape
In simple terms: The enzyme makes it easier for the polypeptide to switch from one shape or assembly to another.
Catalysis of polypeptide conformation or assembly isomerization can be viewed as remodeling the energy landscape so that a different conformational or assembly state becomes accessible. Protein misfolding and aggregation are driven by competing conformational states and intermolecular assembly, and mechanisms that alter these states are directly relevant to GO:0120544. Structural studies of large assemblies such as Mediator and the TELO2-TTI1-TTI2 complex reveal how ordered polypeptide assembly is achieved, providing frameworks for understanding assembly isomerization.
Cofactors and environmental determinants
In simple terms: Ions, charge, and the surrounding environment can influence how the polypeptide changes shape.
Polypeptide conformation is sensitive to charge and environment. Conformational analysis of charged homo-polypeptides shows how electrostatic interactions shape preferred conformations. Dehydrophenylalanine analogues further illustrate how non-canonical residues constrain polypeptide conformation. Ordered conformation can also regulate membrane permeability, linking conformational state to membrane-associated functions. These biophysical determinants inform how cofactors or environmental conditions may modulate GO:0120544 activity.
Assembly of multiprotein complexes
In simple terms: Some enzymes help build large protein machines by changing how subunits fit together.
Assembly isomerization extends beyond single chains to multiprotein complexes. The human Mediator complex and Mediator-bound preinitiation complex provide structural snapshots of ordered polypeptide assembly in transcription regulation. The human TELO2-TTI1-TTI2 complex structure similarly reveals how subunits assemble into a functional machine. These examples illustrate the assembly aspect of GO:0120544, where catalytic or assembly-isomerase-like steps ensure correct subunit arrangement.
Regulation and quality control
In simple terms: Cells monitor polypeptide shape and assembly, and can intervene when something is wrong.
Cells regulate polypeptide conformation and assembly through quality-control pathways that detect misfolded or misassembled states. Protein misfolding and aggregation are recognized as pathological when quality control fails, as reviewed in the context of neurodegeneration. Chromatin-associated factors such as ATRX illustrate how large multidomain proteins participate in complexes where assembly and conformation are functionally important. Regulation of GO:0120544-related activities therefore intersects with proteostasis and assembly surveillance.
Key Genes Involved in GO:0120544 polypeptide conformation or assembly isomerase activity
The following genes and proteins are experimentally tractable entry points for studying polypeptide conformation or assembly isomerase activity and related assembly processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MED1 | Mediator subunit involved in preinitiation complex assembly | Structural studies of Mediator-bound preinitiation complex |
| MED12 | Mediator subunit in transcriptional regulation | Mediator assembly and conformation |
| MED13 | Mediator subunit in transcriptional regulation | Mediator assembly and conformation |
| CDK8 | Mediator-associated kinase | Mediator complex assembly and function |
| TTI1 | TELO2-TTI1-TTI2 complex subunit | Assembly of TELO2-TTI1-TTI2 complex |
| TTI2 | TELO2-TTI1-TTI2 complex subunit | Assembly of TELO2-TTI1-TTI2 complex |
| TELO2 | TELO2-TTI1-TTI2 complex subunit | Assembly of TELO2-TTI1-TTI2 complex |
| ATRX | Chromatin remodeler with multidomain architecture | Conformation and assembly in chromatin complexes |
| HSPA1A | Molecular chaperone | Proteostasis and misfolding |
| HSP90AA1 | Molecular chaperone | Proteostasis and conformational maturation |
| BAG3 | Co-chaperone in proteostasis | Protein quality control and aggregation |
| VCP | AAA-ATPase in protein quality control | Misfolded protein handling |
| SQSTM1 | Autophagy receptor | Aggregate clearance |
| MAPT | Microtubule-associated protein | Conformational change and aggregation in neurodegeneration |
| SNCA | Alpha-synuclein | Conformational transition and aggregation |
| HTT | Huntingtin | Misfolding and aggregation in disease |
| TARDBP | TDP-43 RNA-binding protein | Misfolding and aggregation in neurodegeneration |
How Is polypeptide conformation or assembly isomerase activity Regulated?
Regulation of polypeptide conformation or assembly isomerase activity is tied to proteostasis networks that monitor protein folding and assembly. Protein misfolding and aggregation are controlled by chaperones, degradation pathways, and quality-control factors, and failure of these systems is linked to disease. Large assemblies such as Mediator and TELO2-TTI1-TTI2 are regulated by ordered subunit interactions and structural constraints. Chromatin-associated multidomain proteins like ATRX further illustrate how assembly and conformation are integrated into regulatory complexes. Thus, regulation operates at the level of conformational quality control, assembly stoichiometry, and complex-specific structural requirements.
polypeptide conformation or assembly isomerase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MAPT | Neurodegeneration with tau aggregation | Knock-in of disease-associated point mutations |
| SNCA | Synucleinopathy with alpha-synuclein aggregation | Overexpression and point-mutation models |
| HTT | Huntington disease with polyglutamine aggregation | Knock-in of expanded repeats |
| ATRX | Cancer and chromatin-associated biology | Knockout and point-mutation models |
| TELO2 | Assembly-related cellular stress biology | Knockout of TELO2-TTI1-TTI2 subunits |
Neurodegeneration and protein misfolding
Protein misfolding and aggregation are central mechanisms in neurodegenerative disease, where conformational transitions lead to toxic assemblies. GO:0120544-related activities that alter polypeptide conformation are therefore directly relevant to understanding how misfolding is initiated or reversed.
Cancer and chromatin-associated assembly
ATRX has emerging roles in cancer, and its function depends on multidomain conformation and assembly within chromatin-modifying complexes. Disruption of such assembly processes can contribute to oncogenesis.
Transcriptional dysregulation via Mediator
The Mediator complex is a large multiprotein assembly whose structural integrity is required for preinitiation complex formation. Perturbations in Mediator subunit assembly can alter transcriptional programs relevant to disease.
Assembly defects in TELO2-TTI1-TTI2
The TELO2-TTI1-TTI2 complex is a multiprotein assembly whose structure has been determined, providing a basis for understanding assembly-related dysfunction. Defects in such complexes can impact cellular stress and growth control.
From polypeptide conformation or assembly isomerase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for polypeptide assembly? | CRISPR knockout |
| Does a specific residue control conformational transition? | CRISPR point mutation |
| Can a disease-associated variant alter assembly? | CRISPR knock-in |
| Where does the protein localize during assembly? | Tagged knock-in |
| Does increased dosage drive aggregation? | CRISPR overexpression |
| Which genes modify conformational phenotypes? | CRISPR library screening |
How to Study the polypeptide conformation or assembly isomerase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NMR spectroscopy | Polypeptide conformation in solution | Model polypeptide conformational analysis |
| Circular dichroism | Secondary structure and conformational changes | Analogue conformational characterization |
| Cryo-EM | Structures of large multiprotein assemblies | Mediator and TELO2-TTI1-TTI2 complexes |
| Membrane permeability assay | Functional impact of ordered conformation | Vesicular membrane studies |
| Aggregation assays | Misfolding and aggregate formation | Neurodegeneration-related mechanisms |
| CRISPR knockout | Gene requirement for assembly or conformation | Causal gene testing |
| CRISPR point mutation | Residue-level conformational control | Mechanistic dissection |
| CRISPR knock-in | Disease variant effects on assembly | Variant functionalization |
Biophysical conformational analysis
NMR and related biophysical methods are used to characterize polypeptide conformation, as demonstrated in studies of prebiotic polypeptides and charged homo-polypeptides. Circular dichroism and conformational characterization of analogues such as dehydrophenylalanine derivatives further define how sequence controls conformation.
Structural biology of assemblies
Cryo-EM and crystallography reveal how large multiprotein assemblies are organized, as shown for the human Mediator and the TELO2-TTI1-TTI2 complex. These structures provide templates for interpreting assembly isomerization events.
Membrane and conformational functional assays
Ordered conformation can regulate vesicular membrane permeability, providing functional readouts that connect conformation to membrane behavior. Such assays complement structural and biophysical approaches.
Disease-relevant aggregation assays
Protein misfolding and aggregation can be monitored using biochemical and cellular assays that detect conformational transitions and aggregate formation. These assays link molecular conformation to disease phenotypes.
How CRISPR Can Be Used to Study GO:0120544 polypeptide conformation or assembly isomerase activity
Knockout
CRISPR knockout of candidate genes can test whether a gene is required for polypeptide conformation or assembly processes. For example, knocking out subunits of the TELO2-TTI1-TTI2 complex can reveal assembly dependencies, while knockout of chromatin-associated factors like ATRX can probe complex assembly in chromatin contexts.
Point Mutation
CRISPR point mutation enables residue-level interrogation of conformational transitions. Introducing specific mutations into genes encoding assembly subunits, such as Mediator components, allows testing of which residues control conformation or assembly isomerization.
Knock-in
CRISPR knock-in can introduce disease-associated variants to model conformational or assembly defects. For example, knock-in of neurodegeneration-related variants in genes such as MAPT or SNCA can link conformational changes to aggregation phenotypes.
Overexpression
CRISPR overexpression can drive increased dosage of proteins involved in conformation or assembly, testing whether excess protein promotes aggregation or misassembly. This is particularly relevant for aggregation-prone proteins implicated in neurodegeneration.
How EDITGENE Supports polypeptide conformation or assembly isomerase activity Research
Researchers studying polypeptide conformation or assembly isomerase activity-related genes often need to determine whether a candidate gene is causally involved in conformational transitions, assembly, or disease-associated aggregation. EDITGENE provides CRISPR-based cell models and screening services that enable such causal testing in relevant cellular contexts.
Contact EDITGENE today to design your custom CRISPR model for polypeptide conformation or assembly isomerase activity research.
Frequently Asked Questions About polypeptide conformation or assembly isomerase activity
What is GO:0120544?
GO:0120544 is the Gene Ontology molecular_function term polypeptide conformation or assembly isomerase activity, defined as catalysis of a reaction that alters the conformation or assembly of a polypeptide.
What does polypeptide conformation or assembly isomerase activity mean?
It describes catalytic activities that change how a polypeptide is folded or how polypeptide subunits are assembled, rather than simply binding or stabilizing them.
What genes are involved in polypeptide conformation or assembly isomerase activity?
Genes encoding subunits of large assemblies such as Mediator (for example MED1, MED12) and the TELO2-TTI1-TTI2 complex (TELO2, TTI1, TTI2) are relevant experimental entry points.
How is polypeptide conformation studied experimentally?
NMR, circular dichroism, and computational conformational analysis of model polypeptides are commonly used to characterize polypeptide conformation.
Why is polypeptide misfolding important in disease?
Protein misfolding and aggregation are central mechanisms in neurodegeneration and other proteinopathies, making conformational transitions disease-relevant.
What is the difference between a chaperone and a conformation isomerase?
Chaperones typically bind and stabilize polypeptides, whereas a conformation or assembly isomerase activity catalyzes a change in polypeptide conformation or assembly state.
Which complexes illustrate polypeptide assembly?
The human Mediator complex and the TELO2-TTI1-TTI2 complex are structurally characterized examples of ordered polypeptide assembly.
Can CRISPR be used to study polypeptide conformation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes involved in conformation and assembly.
What methods measure assembly of multiprotein complexes?
Cryo-EM and crystallography are used to determine structures of large assemblies such as Mediator and TELO2-TTI1-TTI2.
How does charge affect polypeptide conformation?
Conformational analysis of charged homo-polypeptides shows that electrostatic interactions influence preferred conformations.
Conclusion
GO:0120544, polypeptide conformation or assembly isomerase activity, defines a molecular function centered on catalyzing changes in polypeptide conformation or assembly. Its importance spans biophysical studies of model polypeptides, structural analysis of large assemblies, and disease mechanisms rooted in misfolding and aggregation. By combining structural, biophysical, and CRISPR-based approaches, researchers can dissect how conformational and assembly transitions are controlled and how they go awry in disease.
References
- 1. Louros N et al.. 2023. Mechanisms and pathology of protein misfolding and aggregation.. Nat Rev Mol Cell Biol 24(12):912-933 PMID: 37684425
- 2. Andini S et al.. 1975. NMR studies of prebiotic polypertides.. Orig Life 6(1-2):147-53 PMID: 1153177
- 3. Chen X et al.. 2021. Structures of the human Mediator and Mediator-bound preinitiation complex.. Science 372(6546) PMID: 33958484
- 4. Bigman LS et al.. 2023. Conformational Analysis of Charged Homo-Polypeptides.. Biomolecules 13(2) PMID: 36830732
- 5. Zheng Y et al.. 2021. Ordered Conformation-Regulated Vesicular Membrane Permeability.. Angew Chem Int Ed Engl 60(41):22529-22536 PMID: 34390299
- 6. Siddiqui MZ. 1999. Dehydrophenylalanine analogues: conformational characterization.. Int J Biol Macromol 26(1):17-21 PMID: 10520952
- 7. Kim Y et al.. 2022. Structure of the Human TELO2-TTI1-TTI2 Complex.. J Mol Biol 434(2):167370 PMID: 34838521
- 8. Watson LA et al.. 2015. Emerging roles of ATRX in cancer.. Epigenomics 7(8):1365-78 PMID: 26646632
